Herbal formula FBD extracts prevented brain injury and inflammation induced by cerebral ischemia-reperfusion

Journal of Ethnopharmacology

Volumn 118, Issue 1, 2008, Pages 140-147

  Lin, Zhihong ^a   Zhu, Danni ^a   Yan, Yongqing ^a   Yu, Boyang ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Angelica sinensis; Anti inflammatory; Atractylodes macrocephala; Common carotid arteries occlusion; Poria cocos; Stroke

Indexed keywords

ANGELICA SINENSIS EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; EVANS BLUE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; NEURON SPECIFIC ENOLASE; PHORBOL 13 ACETATE 12 MYRISTATE; PORIA COCOS EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANGELICA SINENSIS; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATRACTYLODES MACROCEPHALA; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CELL ADHESION; CELL INFILTRATION; CELL STRAIN; CELL STRAIN ECV304; CONTROLLED STUDY; DOWN REGULATION; ENCEPHALITIS; ENDOTHELIUM CELL; IC 50; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MEDICINAL PLANT; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NEUTROPHIL; NONHUMAN; PORIA COCOS; PROTEIN EXPRESSION; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

ANGELICA SINENSIS; ANIMALS; ATRACTYLODES; BRAIN INJURIES; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-8; MALE; MICE; MICE, INBRED ICR; NEUROPROTECTIVE AGENTS; NEUTROPHIL INFILTRATION; NF-KAPPA B; POLYPORALES; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

ANGELICA SINENSIS; ATRACTYLODES MACROCEPHALA; MUS; PORIA COCOS; RATTUS;

EID: 44149098000     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.03.023     Document Type: Article

References (49)

1. Beray-Berthat V., Palmier B., Plotkine M., and Margaill I. Neutrophils do not contribute to infarction, oxidative stress, and NO synthase activity in severe brain ischemia. Experimental Neurology 182 (2003) 446-454
2. 2+ concentration at baseline and after chemotactic activation. Stroke 31 (2000) 1578-1582
3. Cechetto D.F. Role of nuclear factor kappa B in neuropathological mechanisms. Progress in Brain Research 132 (2001) 391-404
4. Chamorro A., and Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37 (2006) 291-293
5. Chen L., Vicaut E., and Sercombe R. Polymorphonuclear leukocyte activation induces cerebral hypoperfusion in rats in the absence of previous ischemia-reperfusion damage. Neuroscience Letters 331 (2002) 203-207
6. Cho K.O., Kim S.K., Cho Y.J., Sung K.W., and Kim S.Y. Regional differences in the neuroprotective effect of minocycline in a mouse model of global forebrain ischemia. Life Sciences 80 (2007) 2030-2035
7. Chou W.H., Choi D.S., Zhang H., Mu D., McMahon T., Kharazia V., Lowell C., Ferriero D.M., and Messing O. Neutrophil protein kinase C delta as a mediator of stroke reperfusion injury. The Journal of Clinical Investigation 114 (2004) 49-56
8. Cuellar M.J., Giner R.M., Recio M.C., Just M.J., Manez S., and Rios J.L. Effect of the basidiomycete Poria cocos on experimental dermatitis and other inflammatory conditions. Chemical & Pharmaceutical Bulletin 45 (1997) 492-494
9. Danton G.H., and Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. Journal of Neuropathology and Experimental Neurology 62 (2003) 127-136
10. Davies C.A., Loddick S.A., Stroemer R.P., Hunt J., and Rothwell N.J. An integrated analysis of the progression of cell responses induced by permanent focal middle cerebral artery occlusion in the rat. Experimental Neurology 154 (1998) 199-212
11. Dinarello C.A. Development and use of a radioimmunoassay for human interleukin-1 beta. Lymphokine Research 6 (1987) 229-244
12. Dinkel K., Dhabhar F.S., and Sapolsky R.M. Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 331-336
13. Dong W.X., Ruan K.F., Gu F.H., Shen P.N., Li P.Y., and Lin Z.H. FBD used to improve learning and memory function of animals. Chinese Traditional and Herbal Drugs 37 (2006) 1831-1835
14. Fuchs S.M., Heinemann C., Schliemann-Willers S., Hartl H., Fluhr J.W., and Elsner P. Assessment of anti-inflammatory activity of Poria cocos in sodium lauryl sulphate-induced irritant contact dermatitis. Skin Research and Technology 12 (2006) 223-227
15. Giner Larza E.M., Manez S., Giner Pons R.M., Recio M.C., and Rios J.L. On the anti-inflammatory and anti-phospholipase A-2 activity of extracts from lanostane-rich species. Journal of Ethnopharmacology 73 (2000) 61-69
16. Gong X.D., and Sucher N.J. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Trends in Pharmacological Sciences 20 (1999) 191-196
17. Huang J., Upadhyay U.M., and Tamargo R.J. Inflammation in stroke and focal cerebral ischemia. Surgical Neurology 66 (2006) 232-245
18. Kaminaga T., Yasukawa K., Takido M., Tai T., and Nunoura Y. Inhibitory effect of Poria cocos on 12-O-tetradecanoylphorbol-13-acetate-induced ear edema and tumour promotion in mouse skin. Phytotherapy Research 10 (1996) 581-584
19. Kostulas N., Pelidou S.H., Kivisäkk P., Kostulas V., and Link H. Increased IL-1β, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30 (1999) 2174-2179
20. Li C., Yan Y., and Sun R. Comparative study on the inhibitory elastase capacity of fructus Forsythiae, radix Salviae Miltiorrhizae, radix Angelicae Sinensis and Ligustrazini. Zhongguo Zhong Yao Za Zhi 15 (1990) 559-561 578
21. Li C.Q., He L.C., and Jin J.Q. Atractylenolide I and atractylenolide III inhibit lipopolysaccharide-induced TNF-alpha and NO production in macrophages. Phytotherapy Research 21 (2007) 347-353
22. Li C.Q., He L.C., Dong H.Y., and Jin J.Q. Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz. Journal of Ethnopharmacology 114 (2007) 212-217
23. Li X.M., Bai X.C., Qin L.N., Huang H., Xiao Z.J., and Gao T.M. Neuroprotective effects of Buyang Huanwu decoction on neuronal injury in hippocampus after transient forebrain ischemia in rats. Neuroscience Letters 346 (2003) 29-32
24. Lin Z., Zhu D., Yan Y., Yu B., and Wang Q. Protective effects of FBD-an experimental Chinese traditional medicinal formula on memory dysfunction in mice induced by cerebral ischemia-reperfusion. Journal of Ethnopharmacology 97 (2005) 477-483
25. Liu Y.M., Zhang J.J., and Jiang J. Observation on clinical effect of Angelica injection in treating acute cerebral infarction. Zhongguo Zhong Xi Yi Jie He Za Zhi 24 (2004) 205-208
26. Ma H., Kou J., Zhu D., Yan Y., and Yu B. Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-α levels, MDA content and enhancing macrophage phagocytosis. International Immunopharmacology 6 (2006) 1355-1362
27. Mo S.J., Son E.W., Lee S.M., Shin D.H., and Pyo S. CML-1 inhibits TNF-α-induced NF-κB activation and adhesion molecule expression in endothelial cells through inhibition of IκB kinase. Journal of Ethnopharmacology 109 (2007) 78-86
28. Moseley R., Waddington R.J., and Embery G. Degradation of glycosaminoglycans by reactive oxygen species, derived from stimulated polymorphonuclear leukocytes. Biochimica et Biophysica Acta 1362 (1997) 221-231
29. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866
30. Prieto J.M., Recio M.C., Giner R.M., Manez S., Giner-Larza E.M., and Rios J.Z. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. The Journal of Pharmacy and Pharmacology 55 (2003) 1275-1282
31. Rampart M., Herman A.G., Grillet B., Opdenakker G., and Van Damme J. Development and application of a radioimmunology for interloukin-8: detection of interloukin-8 in synovial fluids from patients with inflammatory joint disease. Laboratory Investigation 66 (1992) 512-518
32. Rosenberg G.A. Ischemic brain edema. Progress in Cardiovascular Diseases 42 (1999) 209-216
33. Samson Y., Lapergue B., and Hosseini H. Inflammation and ischaemic stroke: current status and future perspectives. Revue Neurologique 161 (2005) 1177-1182
34. Schierwagen C., Bylund-Fellenius A.C., and Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. Journal of Pharmacological Methods 3 (1990) 179-186
35. Schinella G.R., Tournier H.A., Prieto J.M., Mordujovich de Buschiazzo P., and Ríos J.L. Antioxidant activity of anti-inflammatory plant extracts. Life Sciences 70 (2002) 1023-1033
36. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., and Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Natural Medicine 5 (1999) 554-559
37. Schroeter M., Kury P., and Jander S. Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice. Molecular Brain Research 117 (2003) 1-7
38. Strieter R.M., Kunkel S.L., Showell H.J., Remick D.G., Phan S.H., Ward P.A., and Marks R.M. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS and IL-1β. Science 243 (1989) 1467-1469
39. Teppo A.M., and Maury C.P.J. Radioimmunoassay of tumor necrosis factor in serum. Clinical Chemistry 33 (1987) 2024-2027
40. Tseng J., and Chang J.G. Suppression of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and granulocyte-monocyte colony stimulating factor secretion from human monocytes by an extract of Poria cocos. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 25 (1992) 1-11
41. Vexler Z.S., Tang X.N., and Yenari M.A. Inflammation in adult and neonatal stroke. Clinical Neuroscience Research 6 (2006) 293-313
42. Waddick K.G., and Uckun F.M. Innovative treatment programs against cancer. II. Nuclear factor-kappa B (NF-κB) as a molecular target. Biochemical Pharmacology 57 (1999) 9-17
43. Wang X.J., and Feng P. Antioxidant activity of qizhu tang. Acta Pharmacologica Sinica 21 (2000) 1141-1144
44. Weston R.M., Jones N.M., Jarrott B., and Callaway J.K. Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. Journal of Cerebral Blood Flow and Metabolism 27 (2007) 100-114
45. Xu H.L., and Feng Y.P. Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats. Acta Pharmacologica Sinica 21 (2000) 433-438
46. Yan B., Bi X., He J., Zhang Y., Thakur S., Xu H., Gendron A., Kong J., and Li X.M. Quetiapine attenuates spatial memory impairment and hippocampal neurodegeneration induced by bilateral common carotid artery occlusion in mice. Life Sciences 81 (2007) 353-361
47. Yang Q., Goto H., Hikiami H., Shibahara N., Shimada Y., Terasawa K., and Tang F. Effects of Toki-shakuyaku-san on microcirculation of bulbar conjunctiva and hemorheological factors in patients with asymptomatic cerebral infarction. Journal of Traditional Medicines 21 (2004) 170-173
48. Zhang Z.G., Zhang L., Croll S.D., and Chopp M. Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice. Neuroscience 113 (2002) 683-687
49. Zhou S.N., Wang Q.J., and Zhu D.N. The effect of optimized Danggui Shaoyao San (FBD) on cerebral ischemia reperfusion. Chinese Journal of Experimental Traditional Medical Formulae 12 (2006) 47-50